The interaction between ataxin-3 and Rad23 regulates polyglutamine toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.

被引：0
|
作者：
Sutton, J. R. [1 ]
Blount, R. [1 ]
Todi, S. V. [1 ]
机构：
[1] Wayne State Univ, Sch Med, Pharmacol, Detroit, MI USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P815
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3
    Sutton, Joanna R.
    Blount, Jessica R.
    Libohova, Kozeta
    Tsou, Wei-Ling
    Joshi, Gnanada S.
    Paulson, Henry L.
    Costa, Maria do Carmo
    Scaglione, K. Matthew
    Todi, Sokol V.
    HUMAN MOLECULAR GENETICS, 2017, 26 (08) : 1419 - 1431
  • [2] Differential toxicity of ataxin-3 isoforms in Drosophila models of Spinocerebellar Ataxia Type 3
    Johnson, Sean L.
    Blount, Jessica R.
    Libohova, Kozeta
    Ranxhi, Bedri
    Paulson, Henry L.
    Tsou, Wei-Ling
    Todi, Sokol V.
    NEUROBIOLOGY OF DISEASE, 2019, 132
  • [3] Lysine 117 on ataxin-3 modulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3
    Blount, Jessica R.
    Patel, Nikhil C.
    Libohova, Kozeta
    Harris, Autumn L.
    Tsou, Wei-Ling
    Sujkowski, Alyson
    Todi, Sokol V.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 454
  • [4] Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in Drosophila models of Spinocerebellar Ataxia Type 3
    Prifti, Matthew V.
    Libohova, Kozeta
    Harris, Autumn L.
    Tsou, Wei-Ling
    Todi, Sokol V.
    FRONTIERS IN NEUROSCIENCE, 2023, 16
  • [5] The disease protein ataxin-3 forms intranuclear aggregates in the CAG/polyglutamine disorder spinocerebellar ataxia type 3.
    Perez, MK
    Pittman, RN
    Trojanowski, JQ
    Subramony, SH
    Fratkin, J
    Trottier, Y
    Mandel, JL
    Paulson, HL
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A4 - A4
  • [6] Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3
    Koike, Yuka
    Jansen-West, Karen R.
    Al-Shaikh, Rana Hanna
    Carlomagno, Yari
    Song, Yuping
    Dunmore, Judith A.
    LeDoux, Mark S.
    Friedman, Joseph H.
    Pena, Ashley B.
    Uitti, Ryan J.
    Zaremba, Jacek
    van Gerpen, Jay A.
    Pfeiffer, Ronald F.
    Veerappan, Venka
    Aiba, Ikuko
    Hashimoto, Rina
    Giles, Samuel S.
    Shah, Jaimin S.
    Tipton, Philip W.
    Huang, Josephine F.
    Wierenga, Klaas J.
    Aasly, Jan
    Fryer, John D.
    Petrucelli, Leonard
    Wszolek, Zbigniew K.
    Prudencio, Mercedes
    PARKINSONISM & RELATED DISORDERS, 2021, 89 : 151 - 154
  • [7] Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models
    Matos, Carlos A.
    Nobrega, Clevio
    Louros, Susana R.
    Almeida, Bruno
    Ferreiro, Elisabete
    Valero, Jorge
    de Almeida, Luis Pereira
    Macedo-Ribeiro, Sandra
    Carvalho, Ana Luisa
    JOURNAL OF CELL BIOLOGY, 2016, 212 (04): : 465 - 480
  • [8] Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood
    Huebener-Schmid, Jeannette
    Kuhlbrodt, Kirsten
    Peladan, Julien
    Faber, Jennifer
    Santana, Magda M.
    Hengel, Holger
    Jacobi, Heike
    Reetz, Kathrin
    Garcia-Moreno, Hector
    Raposo, Mafalda
    van Gaalen, Judith
    Infante, Jon
    Steiner, Katharina M.
    de Vries, Jeroen
    Verbeek, Marcel M.
    Giunti, Paola
    Pereira de Almeida, Luis
    Lima, Manuela
    van de Warrenburg, Bart
    Schoels, Ludger
    Klockgether, Thomas
    Synofzik, Matthis
    Riess, Olaf
    MOVEMENT DISORDERS, 2021, 36 (11) : 2675 - 2681
  • [9] Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of Spinocerebellar Ataxia Type 3
    Johnson, Sean L.
    Libohova, Kozeta
    Blount, Jessica R.
    Sujkowski, Alyson L.
    Prifti, Matthew, V
    Tsou, Wei-Ling
    Todi, Sokol, V
    NEUROBIOLOGY OF DISEASE, 2021, 160
  • [10] Comment on: Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood
    Hanna AL-Shaikh, Rana
    Jansen-West, Karen R.
    Petrucelli, Leonard
    Wszolek, Zbigniew K.
    Prudencio, Mercedes
    MOVEMENT DISORDERS, 2022, 37 (05) : 1120 - 1121
12345